Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2026-05-18 14:03:23 ET · period of report 2026-05-15 · accession 0001214659-26-006532 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-18 14:03 | 2026-05-15 | AQST | Barber Daniel | Pres, CEO | S - Sale | $4.29 | -8,257 | 660.6K | -1% | -$35.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | S | D | 8,257 | $4.29 | 660,574 | D | — | — | (F1) The reported transaction involves sale transactions from $4.17 to $4.64 per share. The weighted average price per share was $4.2889. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. |